ICD-10 Code D52.1 | Drug-induced folate deficiency anemia Symptoms, Diagnosis, Billing

Drug-induced folate deficiency anemia is a type of anemia caused by the interference of certain medications with folate metabolism or absorption. This condition is clinically significant as it can lead to serious health complications if not identified and treated promptly. The ICD-10 Code D52.1 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this condition.

What is ICD-10 Code D52.1 for Drug-induced folate deficiency anemia?

ICD-10 Code D52.1 represents Drug-induced folate deficiency anemia, which occurs when certain drugs inhibit folate absorption or metabolism, leading to decreased red blood cell production. This code should be used in clinical documentation and billing when a patient's anemia is directly linked to medication use, ensuring proper identification and management of the condition.

ICD-10 Code D52.1 – Clinical Definition and Explanation of Drug-induced folate deficiency anemia

Drug-induced folate deficiency anemia arises from the adverse effects of specific medications that disrupt folate metabolism, leading to insufficient folate levels necessary for red blood cell production. This condition requires medical attention to prevent complications such as severe anemia and associated symptoms.

Key Clinical Features:

• Fatigue and weakness due to reduced hemoglobin levels
• Pallor and shortness of breath on exertion
• Glossitis or mouth ulcers as oral manifestations
• Elevated mean corpuscular volume (MCV) on complete blood count

ICD-10 Code D52.1 for Drug-induced folate deficiency anemia – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code D52.1 is utilized to document the diagnosis of Drug-induced folate deficiency anemia, aiding in the assessment of symptoms, treatment plans, and patient management. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation.

What Does ICD-10 Code D52.1 for Drug-induced folate deficiency anemia Mean in SOAP Notes?

ICD-10 Code D52.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Drug-induced folate deficiency anemia. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D52.1 – Drug-induced folate deficiency anemia

Prompt treatment of Drug-induced folate deficiency anemia is crucial to prevent complications. Management typically involves discontinuing the offending medication and supplementing folate as needed.

Antibiotic Therapy:

Supportive Care:

• Folate supplementation (oral or intravenous) based on severity
• Monitoring of hemoglobin levels and reticulocyte count
• Patient education on dietary sources of folate

Infection Control:

How to Document Symptoms of Drug-induced folate deficiency anemia (ICD-10 D52.1) in SOAP Notes

Subjective:

• Patient reports fatigue and weakness over the past month
• History of recent medication changes including methotrexate
• Complaints of mouth sores and difficulty swallowing
• Denies any recent infections or significant weight loss

Objective:

• Pallor noted on physical examination
• Complete blood count shows low hemoglobin and elevated MCV
• Reticulocyte count is low
• Folate levels are below normal range

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Drug-induced folate deficiency anemia (ICD-10 Code D52.1)

Assessment:

• Diagnosis: Drug-induced folate deficiency anemia, moderate severity
• ICD-10 Code: D52.1
• Contributing factors: Recent use of methotrexate
• Patient's dietary intake may also be insufficient

Plan:

• Discontinue methotrexate and consider alternative therapies
• Initiate oral folate supplementation (1 mg daily)
• Schedule follow-up in 2 weeks to monitor hemoglobin levels
• Educate patient on dietary sources of folate and importance of adherence

Treatment & Plan Section for ICD-10 Code D52.1 – Drug-induced folate deficiency anemia

• First-line treatment includes folate supplementation to restore levels
• Monitor hemoglobin and reticulocyte counts to assess response to treatment
• Educate patients on dietary modifications to include folate-rich foods
• Follow-up appointments are essential to ensure resolution of anemia

Using ICD-10 Code D52.1 for Drug-induced folate deficiency anemia in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and medication history in Subjective (S) and Objective (O) sections
• Use D52.1 in conjunction with other relevant codes for comprehensive billing
• Align treatment plans with clinical guidelines to support justified billing
• Document patient education and follow-up plans to meet EHR standards

Related ICD-10 Codes Often Used with Drug-induced folate deficiency anemia

• D50.0 – Iron deficiency anemia due to blood loss
• D53.1 – Other nutritional anemia

ICD-10 Code D52.1 in Medical Billing and Insurance for Drug-induced folate deficiency anemia

ICD-10 Code D52.1 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings, ensuring accurate representation of the patient's condition.

Billing Notes:

• Document the patient's medication history thoroughly to support the diagnosis
• Use D52.1 in the primary diagnosis field when billing for anemia-related services
• Ensure all relevant clinical findings are included in the medical record to justify the claim

Common CPT Pairings: